Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Placebo subjects tended to lose less and regain it more slowly after the study ended
If your provider is still offering them, that could be a major red flag
When you come in for your consultation and your treatment plan is created, our Patient Coordinator will be able to provide you with a breakdown which will then give you a much better idea of the cost for the entirety of your treatment
Retatrutide is not eligible for compounding under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act because it is not on the FDAs approved compounding list
You can find one in your area at Find a Dermatologist
Analysis performed under standard reversed-phase chromatographic conditions with LCMS/MS confirmation of molecular mass
US$ 28.33
US$ 24.45
US$ 26.79
US$ 29.28
US$ 21.51
